SCHEMBL8647221

SCHEMBL8647221

CCCCCCCCCCCCN(C)CC(CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O)OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 5/20 0.55
▸ ADORA2B P29275 5/20 0.55
▸ PDE4A P27815 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ NFKB1 P19838 2/20 0.55
▸ ACHE P22303 2/20 0.55
▸ PMP22 Q01453 2/20 0.55
▸ PDE4B Q07343 2/20 0.55
▸ PDE4C Q08493 2/20 0.55
▸ PDE4D Q08499 2/20 0.55
▸ USP2 O75604 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ ESR1 P03372 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ BCHE P06276 1/20 0.46
▸ ADORA2A P29274 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8647045 0.91 TNF (0.55) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8649864 0.91 TNF (0.54) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8647650 0.91 TNF (0.54) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8593186 0.91 TNF (0.54) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8648823 0.91 TNF (0.54) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8379556 0.86 ADORA2B (0.53) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL4999242 0.86 ADORA2B (0.53) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8644659 0.85 TNF (0.55) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL8647043 0.83 TNF (0.52) TNFADORA2BPDE4ALMNACYP1A2
SCHEMBL7611719 0.82 ADORA2B (0.61) TNFADORA2BPDE4ALMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670507-A Method for reversing multiple drug resistant phenotype CELL THERAPEUTICS, INC. (US) 1997-09-23 — — US claimed
US-5824677-A SUBSTITUTED WITH HETEROCYCLIC RING, ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE CELL THERAPEUTICS, INC. (US) 1998-10-20 — — US disclosed
US-5807862-A Therapeutic compounds containing pyrimidinyl moieties CELL THERAPEUTICS, INC. (US) 1998-09-15 — — US disclosed
US-5750575-A ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANTS; CYTOTOXIC AGENTS; MICROBIOCIDES; FUNGICIDES CELL THERAPEUTICS, INC. (US) 1998-05-12 — — US disclosed
US-5670507-A Method for reversing multiple drug resistant phenotype CELL THERAPEUTICS, INC. (US) 1997-09-23 — — US disclosed
US-5641783-A ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS CELL THERAPEUTICS, INC. (US) 1997-06-24 — — US disclosed
WO-1995013808-A1 METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION CELL THERAPEUTICS, INC. (US) 1995-05-26 — — WO disclosed
Send feedback